Evidence map›Paper›PMID 39188886›Full record

ArticleIJID regions2024

Tick-borne encephalitis seroprevalence in northern Italy: a cross-sectional study on a randomly selected population.

Antonella Castagna, Stefania Schiavon, Giulio Mengozzi, Tatjana Baldovin, Silvia Nozza, Diana Canetti, Silvia Cocchio, Eva Agostina Montuori, Raffaella Iantomasi, Vincenzo Baldo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in IJID regions, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. New Aspects on Tick-borne Encephalitis in Children.The Pediatric infectious disease journal · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Antonella CastagnaClinic of Infectious Diseases, Vita-Salute San Raffaele University, San Raffaele Scientific Institute, Milan, Italy.
Stefania SchiavonOspedale Cà Foncello di Treviso ULSS2 Marca Trevigiana, UOC Microbiologia, Treviso, Italy.
Giulio MengozziAzienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Dipartimento di Medicina di Laboratorio, Torino, Italy.
Tatjana BaldovinDepartment of Cardiac, Thoracic, Vascular Sciences and Public Health, Laboratory of Hygiene and Applied Microbiology, Unit of Hygiene and Public Health, University of Padua, Padua, Italy.
Silvia NozzaClinic of Infectious Diseases, Vita-Salute San Raffaele University, San Raffaele Scientific Institute, Milan, Italy.
Diana CanettiClinic of Infectious Diseases, Vita-Salute San Raffaele University, San Raffaele Scientific Institute, Milan, Italy.
Silvia CocchioDepartment of Cardiac, Thoracic, Vascular Sciences and Public Health, Unit of Hygiene and Public Health, University of Padua, Padua, Italy.
Eva Agostina MontuoriPfizer Italy srl, Via Valbondione 113, Roma, Italy.
Raffaella IantomasiPfizer Italy srl, Via Valbondione 113, Roma, Italy.
Vincenzo BaldoDepartment of Cardiac, Thoracic, Vascular Sciences and Public Health, Unit of Hygiene and Public Health, University of Padua, Padua, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Methods: A multicenter study was conducted on a random sample of the general population afferent to hospitals in Veneto, Lombardy, and Piedmont with a pre-determined sample size of 1500 participants. The presence of TBEV-neutralizing antibodies was determined for sera positive to the TBE-specific immunoglobulin G test in a centralized laboratory. Results: Out of 1537 samples analyzed (790 from Lombardy, 394 from Veneto, 353 from Piedmont), 39 (2.5%) were immunoglobulin G TBEV-positive. The frequency of positive cases was similar amid the regions (24-3.0% Lombardy, 10-2.5% Veneto, and 5-1.4% Piedmont; Conclusions: The results from this study highlight the need for raising awareness among the population and health care workers to limit the risk of TBE infection.

Indexed as

DiagnosticsELISAEncephalitis virusesEpidemiological monitoringEpidemiologyEuropeHumansImmunoassayImmunologyItalyTick-borneVirology

Identifiers

PMID39188886
PMCPMC11347062

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.